Advertisement.

RCHA Projected Dividend Yield

Rich Pharmaceuticals Inc ( OTCBB : RCHA )

Rich Pharmaceuticals is a development stage company. Co. is developing RP-323 for the treatment of Hodgkin's lymphoma (HL), Acute Myelogenous Leukemia (AML), and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The priority drug development efforts of Co. are focused on the use of RP-323, a naturally occurring compound that has a number of properties that are suited for the treatment of patients with HL and AML. During the course of these preliminary clinical studies RP-323 was found to be potent in causing a marked and favorable increase in white blood cells in blood, key elements in fighting infections.

20 YEAR PERFORMANCE RESULTS

RCHA Dividend History Detail
RCHA Dividend News
RCHA Competitors News

# of Shares: 0

Closing Price: 0.00

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000